Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Modular Medical Inc (NQ: MODD )

2.210 -0.010 (-0.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 117,475
Open 2.240
Bid (Size) 2.140 (3)
Ask (Size) 2.230 (12)
Prev. Close 2.220
Today's Range 2.170 - 2.330
52wk Range 1.000 - 2.650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Registration Is Now Open For Tribe Public's Webinar Event "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing" Featuring Modular Medical CEO On Monday, November 11, 2024
Via ACCESSWIRE
Biotech and Technology Giants Drive Innovation Across Pharma, Medical Devices, and Industrial Automation CRDL, MODD, CYN
Via AB Newswire
Exposures Product Safety

Performance

YTD
+1.84%
+1.84%
1 Month
+8.87%
+8.87%
3 Month
+40.76%
+40.76%
6 Month
+28.49%
+28.49%
1 Year
+87.29%
+87.29%

More News

Read More
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
Via ACCESSWIRE
New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"
Via ACCESSWIRE
New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)
Via ACCESSWIRE
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
Via ACCESSWIRE
Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
Via ACCESSWIRE
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024
Via ACCESSWIRE
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
Via ACCESSWIRE
Growth Stocks Across Multiple Sectors-Innovators in Action: MODD, INBS, RCAT, KAVL, WHLR”
Via AB Newswire
Exposures Product Safety
Why Is Modular Medical Stock Up Today?
Via Benzinga
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
Via ACCESSWIRE
Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
Via ACCESSWIRE
MODD Stock Earnings: Modular Medical Beats EPS for Q1 2025
Via InvestorPlace
Registration is Now Open for Tribe Public’s Webinar Event "Diabetes Care Innovator Modular Medical Takes Next Steps" Featuring Modular Medical CEO on Friday, August 9, 2024
Via ACCESSWIRE
Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize
Via ACCESSWIRE
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform
Via ACCESSWIRE
MODD Stock Earnings: Modular Medical Beats EPS for Q4 2024
Via InvestorPlace
Modular Medical Announces Addition to the Russell Microcap(R) Index
Via ACCESSWIRE
Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.